Aisling Capital Management »

Aclaris Therapeutics shares owned by Aisling Capital Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Aisling Capital Management from 13F filings

Historical chart of Aisling Capital Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Aisling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Aisling Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $456k 435k 1.05
2023-09-30 $3.0M 435k 6.85
2023-06-30 $4.5M 435k 10.37
2023-03-31 $3.5M 435k 8.09
2022-12-31 $6.8M 435k 15.75
2022-09-30 $10M 635k 15.74
2022-06-30 $8.9M 635k 13.96
2022-03-31 $11M 635k 17.24
2021-12-31 $9.2M 635k 14.54
2021-09-30 $11M 635k 18.00
2021-06-30 $11M 635k 17.56
2021-03-31 $16M 635k 25.20
2020-12-31 $4.1M 635k 6.47
2020-09-30 $1.6M 635k 2.57
2020-06-30 $1.0M 635k 1.62
2020-03-31 $660k 635k 1.04
2019-12-31 $1.2M 635k 1.89
2019-09-30 $685k 635k 1.08
2019-06-30 $1.4M 635k 2.19
2019-03-31 $3.8M 635k 5.99
2018-12-31 $4.7M 635k 7.39